BADR M. Z. A.; EL-SHERIF H. A. H.; MAHMMOUD A. M., BULL. CHEM. SOC. JAP. ,1980, 53 NO 8, 2389-2392
作者:BADR M. Z. A.、 EL-SHERIF H. A. H.、 MAHMMOUD A. M.
DOI:——
日期:——
AGARWAL, R.;CHAUDHARY, C.;SRIVASTAVA, V. K.;MISRA, V. S., ACTA PHARM. JUGOSL., 1982, 32, N 1, 37-44
作者:AGARWAL, R.、CHAUDHARY, C.、SRIVASTAVA, V. K.、MISRA, V. S.
DOI:——
日期:——
[EN] NEW USE<br/>[FR] NOUVELLE UTILISATION
申请人:CANCER REC TECH LTD
公开号:WO2003007955A2
公开(公告)日:2003-01-30
The present invention provides the use of a low molecular weight mammalian AP endonuclease inhibitor for the preparation of a medicament for the treatment of cancer.